Clinical Features
chronic diarrhea
abdominal pain
borborygmi
marked weight loss
muscle wasting
weakness
edema (low albumin and potassium in blood)
TREATMENT
Albendazole was presently considered the drug of choice for the treatment
of human intestinal capilliariasis because it was effective against eggs,
larvae, and adult worms[1,26]. However, for a major infection,
mebendazole (200 mg orally twice a day for 20 d) was recommended as
the treatment of choice.
Mebendazole at 400 mg/day in two divided doses for 20 days soon
replaced thiabendazole. In patients with relapses the drug was given for
30 days and there were few subse- quent relapses. Albendazole is
presently the drug of choice in a dose similar to that for mebendazole,but
is administered only for 10days.Treatment for less than 10 days has
resulted in relapses in some patients.It is believed that relapses result
PREVENTION
The health education campaign aims to promote the consumption of
cooked fish and to avoid defecation into a water resource in order to
eliminate